APPlife Digital Solutions (ALDS) 10-Q 12 May 22 2022 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Mar. 31, 2022	May 12, 2022
Details
Registrant CIK	0001755101
Fiscal Year End	--06-30
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2022
Document Transition Report	false
Entity File Number	000-54524
Entity Registrant Name	APPLIFE DIGITAL SOLUTIONS, INC.
Entity Incorporation, State or Country Code	NV
Entity Tax Identification Number	30-0678378
Entity Address, Address Line One	50 California St
Entity Address, Address Line Two	#1500
Entity Address, City or Town	San Francisco
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94111
City Area Code	415
Local Phone Number	439 5260
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		148,543,635
Amendment Flag	false
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Mar. 31, 2022	Jun. 30, 2021
Current assets
Cash	$ 167,931	$ 250,073
Prepaid expenses	12,392	34,113
Other current assets	389	0
Inventories	66,390	48,875
Total assets	247,102	333,061
Current liabilities
Accounts payable and accrued expenses	320,439	266,323
Common stock payable	125,616	0
Notes payable - current, net	1,327,838	595,235
Derivative liabilities	172,166	28,576
Due to officer	1,428	6,428
Total current liabilities	1,947,487	896,562
Notes payable - noncurrent, net	100,000	786,925
Total liabilities	2,047,487	1,683,487
Stockholders' deficit
Common stock, $0.001 par value, 500,000,000 shares authorized; 148,543,635 and 135,524,617 shares issued and outstanding as of March 31, 2022 and June 30, 2021, respectively	148,545	135,526
Additional paid-in capital	10,433,659	8,350,779
Accumulated (deficit)	(12,382,589)	(9,836,731)
Total stockholders' deficit	(1,800,385)	(1,350,426)
Total liabilities and stockholders' deficit	$ 247,102	$ 333,061

Consolidated Balance Sheets - P

Consolidated Balance Sheets - Parenthetical - $ / shares	Mar. 31, 2022	Jun. 30, 2021
Details
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	500,000,000	500,000,000
Common Stock, Shares, Issued	148,543,635	135,524,617
Common Stock, Shares, Outstanding	148,543,635	135,524,617

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Details
Revenue	$ 8,475	$ 1,410	$ 10,346	$ 3,716
Cost of goods sold	(5,434)	(3,973)	(6,864)	(5,467)
Gross profit	3,041	(2,563)	3,482	(1,751)
Operating expenses	764,429	757,671	2,288,026	2,414,312
Total operating expenses	764,429	757,671	2,288,026	2,414,312
Loss from operations	(761,388)	(760,234)	(2,284,544)	(2,416,063)
Other income (expense)
Interest expense	(149,494)	(79,241)	(323,789)	(453,048)
Loss on extension of notes payable	0	0	0	(41,214)
Gain on settlement of debt	0	0	48,619	0
Change in fair value of Common Stock	0	0	(11,283)	0
Change in fair value of derivative liability	616	75,733	25,139	78,245
Net loss before provision for income taxes	(910,266)	(763,742)	(2,545,858)	(2,832,080)
Provision for income taxes	0	0	0	0
Net loss	$ (910,266)	$ (763,742)	$ (2,545,858)	$ (2,832,080)
Basic and diluted loss per share	$ (0.02)	$ (0.02)	$ (0.05)	$ 0.07
Average number of common shares outstanding - basic and diluted	50,854,024	41,437,015	50,411,115	39,780,656

Consolidated Statement of Stock

Consolidated Statement of Stockholder's (Deficit) Equity - USD ($)	Common Stock	Additional Paid-in Capital	Retained Earnings	Total
Stockholders' Equity Attributable to Parent, Beginning Balance at Jun. 30, 2020	$ 127,037	$ 5,037,883	$ (5,609,891)	$ (444,971)
Shares, Outstanding, Beginning Balance at Jun. 30, 2020	127,037,531
Common stock issued for cash, Value	$ 1,200	118,800	0	120,000
Common stock issued for cash, Shares	1,200,000
Stock compensation expense	$ 0	(1,120,878)	0	(1,120,878)
Common stock issued for services, Value	$ 5,230	460,148	0	465,378
Common stock issued for services, Shares	5,229,030
Issuance of common stock payable	$ 140	25,096	0	25,236
Issuance of common stock payable, Shares	140,199
Shares issued for prepayment penalty	$ (277)	(45,237)	0	(45,514)
Shares issued for prepayment penalty, Shares	(277,012)
Payment of notes payable with issuance of common stock, Value	$ 604	74,366	0	74,970
Payment of notes payable with issuance of common stock, Shares	604,548
Eliminate derivative liability upon repayment of debt	$ 0	125,238	0	125,238
Equity component of issuance of convertible notes	0	260,333	0	260,333
Net loss	0	0	(2,832,080)	(2,832,080)
Stockholders' Equity Attributable to Parent, Ending Balance at Mar. 31, 2021	$ 134,488	7,309,193	(8,441,971)	(998,290)
Shares, Outstanding, Ending Balance at Mar. 31, 2021	134,488,320
Loss on extension of notes payable	$ 0	(41,214)	0	(41,214)
Stock compensation expense	0	1,120,878	0	1,120,878
Shares issued for prepayment penalty	$ 277	45,237	0	45,514
Shares issued for prepayment penalty, Shares	277,012
Loss on extension of notes payable	$ 0	41,214	0	41,214
Stockholders' Equity Attributable to Parent, Beginning Balance at Dec. 31, 2020	$ 133,960	6,780,958	(7,678,229)	(763,311)
Shares, Outstanding, Beginning Balance at Dec. 31, 2020	133,960,606
Common stock issued for cash, Value	$ 0	0	0	0
Common stock issued for cash, Shares	0
Stock compensation expense	$ 0	417,753	0	417,753
Common stock issued for services, Value	$ 528	70,482	0	71,010
Common stock issued for services, Shares	527,714
Shares issued for prepayment penalty	$ 0	0	0	0
Shares issued for prepayment penalty, Shares	0
Payment of notes payable with issuance of common stock, Value	$ 0	0	0	0
Eliminate derivative liability upon repayment of debt	0	0	0	0
Equity component of issuance of convertible notes	0	40,000	0	40,000
Net loss	0	0	(763,742)	(763,742)
Stockholders' Equity Attributable to Parent, Ending Balance at Mar. 31, 2021	$ 134,488	7,309,193	(8,441,971)	(998,290)
Shares, Outstanding, Ending Balance at Mar. 31, 2021	134,488,320
Loss on extension of notes payable	$ 0	0	0	0
Stock compensation expense	0	(417,753)	0	(417,753)
Shares issued for prepayment penalty	$ 0	0	0	0
Shares issued for prepayment penalty, Shares	0
Loss on extension of notes payable	$ 0	0	0	0
Stockholders' Equity Attributable to Parent, Beginning Balance at Jun. 30, 2021	$ 135,526	8,350,779	(9,836,731)	(1,350,426)
Shares, Outstanding, Beginning Balance at Jun. 30, 2021	135,524,617
Common stock issued for cash, Value	$ 5,200	514,800	0	520,000
Common stock issued for cash, Shares	5,200,000
Stock compensation expense	$ (4,000)	(1,427,758)	0	(1,431,758)
Common stock issued for services, Value	$ 3,819	140,322	0	144,141
Common stock issued for services, Shares	3,819,018
Shares issued for prepayment penalty				0
Eliminate derivative liability upon repayment of debt				0
Net loss	$ 0	0	(2,545,858)	(2,545,858)
Stockholders' Equity Attributable to Parent, Ending Balance at Mar. 31, 2022	$ 148,545	10,433,659	(12,382,589)	(1,800,385)
Shares, Outstanding, Ending Balance at Mar. 31, 2022	148,543,635
Loss on extension of notes payable				0
Stock compensation expense	$ 4,000	1,427,758	0	1,431,758
Shares issued for prepayment penalty				0
Loss on extension of notes payable				0
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture	4,000,000
Stockholders' Equity Attributable to Parent, Beginning Balance at Dec. 31, 2021	$ 146,647	9,904,132	(11,472,323)	(1,421,544)
Shares, Outstanding, Beginning Balance at Dec. 31, 2021	146,645,612
Stock compensation expense	$ 0	491,567	0	491,567
Common stock issued for services, Value	$ 1,898	37,960	0	39,858
Common stock issued for services, Shares	1,898,023
Net loss	$ 0	0	(910,266)	(910,266)
Stockholders' Equity Attributable to Parent, Ending Balance at Mar. 31, 2022	$ 148,545	10,433,659	(12,382,589)	(1,800,385)
Shares, Outstanding, Ending Balance at Mar. 31, 2022	148,543,635
Stock compensation expense	$ 0	$ (491,567)	$ 0	$ (491,567)

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (2,545,858)	$ (2,832,080)
Adjustment to reconcile change in net loss to net cash used in operating activities
Amortization	122,913	231,785
Interest Expense	68,729
Issuance of common stock for services	144,141	465,378
Shares issued for prepayment penalty	0	45,514
Loss on extension of notes payable	0	41,214
Stock compensation expense	1,431,758	1,120,878
Change in fair value of derivative liability	(25,139)	(78,245)
Gain on settlement of debt	(48,619)	0
Changes in operating assets and liabilities
Other Current Assets	(389)	7,574
Prepaid expenses and other current assets	21,721	251,148
Inventories	(17,515)	302
Common stock payable	125,616	235
Accounts payable and accrued expenses	65,500	111,535
Net Cash Provided by (Used in) Operating Activities, Continuing Operations	(657,142)	(634,762)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from notes payable	100,000	1,048,000
Proceeds from issuance of common stock	520,000	120,000
Payment on notes payable	(40,000)	(185,000)
Payment on amounts due to officer	(5,000)	0
Net cash provided from financing activities	575,000	983,000
Net decrease in cash and cash equivalents	(82,142)	348,238
Cash and cash equivalents, beginning of period	250,073	85,707
Cash and cash equivalents, end of period	167,931	433,945
Supplemental disclosure of cash flow information
Cash paid for interest	0	16,153
Cash paid for taxes	0	0
Non-cash investing and financing activities
Eliminate derivative liability upon repayment of debt	0	125,238
Issuance of common stock payable	0	25,236
Equity component of issuance of convertible notes	0	220,333
Payment of notes payable with issuance of common stock	0	74,970
Increase in derivative liability upon issuance of convertible note	$ 168,729	$ 0

Note 1 - Organization and Summa

Note 1 - Organization and Summary of Significant Accounting Policies	9 Months Ended
	Mar. 31, 2022
Notes
Note 1 - Organization and Summary of Significant Accounting Policies	Note 1 – Organization and Summary of Significant Accounting Policies Organization APPlife Digital Solutions Inc. (the “Company”) is a business incubator and portfolio manager that uses digital technology to create and invest in e-commerce and cloud-based solutions. The Company was formed March 5, 2018 in Nevada and has offices in San Francisco, California and Shanghai, China. The Company’s mission is using digital technology to create APPs and websites that make life, business and living easier, more efficient and just smarter. Rooster Essentials APP SPV, LLC (the “Rooster”), incorporated on April 9, 2019, is a wholly owned subsidiary of the Company. Rooster is a fully customizable men’s ecommerce platform that delivers daily use grooming needs and essential items. B2BCHX SPV LLC (the “B2BCHX”), incorporated on June 5, 2019, is a wholly owned subsidiary of the Company. B2BCHX does an independent background check on mainland Chinese companies for small businesses globally. Office Hop, incorporated on January 28, 2021, is a wholly owned subsidiary of the Company. Office Hop is a global sharing model platform for short term rentals of office and meeting rooms. Users can find an office or conference space for hourly, half-day, full-day, or weekly rental. Hosts can list their spare office or meeting rooms. Going Concern The Company has generated losses and negative cash flows from operations since inception. The Company has historically financed its operations from equity financing. The Company anticipates additional equity financings to fund operations in the future. Should management fail to adequately address the issue, the Company may have to reduce its business activities or curtail its operations. There can be no assurance that any additional financings, would be available to the Company on satisfactory terms and conditions if at all. The current pandemic known as COVID-19 as described in Note 5, creates additional uncertainty. The accompanying consolidated financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and classification of liabilities and commitments in the normal course of business. The accompanying consolidated financial statements do not reflect any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classifications of liabilities that might result if the Company is unable to continue as a going concern. Basis of Presentation The Company’s unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for the interim financial information and with instructions to Form 10-Q and Article 10 of Regulation S-X. The unaudited condensed consolidated financial statements include the accounts of all subsidiaries in which the Company holds a controlling financial interest as of the financial statement date. All intercompany transactions have been eliminated in consolidation. However, in the opinion of the management of the Company, all adjustments necessary for a fair presentation of the financial position and operating results have been included in these statements. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10–K for the fiscal year ended June 30, 2021, as filed with the SEC on September 24, 2021. Operating results for the nine months ended March 31, 2022 are not necessarily indicative of the results that may be expected for any subsequent quarters or for the fiscal year ending June 30, 2022. Cash and Cash Equivalents For the purpose of the statement of cash flows, the Company considers cash equivalents to include cash and investments with an original maturity of three months or less. Income Taxes The Company has adopted guidance issued by the FASB that clarifies the accounting for uncertainty in income taxes recognized in an enterprise's financial statements and prescribes a recognition threshold of more likely than not and a measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. In making this assessment, a company must determine whether it is more likely than not that a tax position will be sustained upon examination, based solely on the technical merits of the position and must assume that the tax position will be examined by taxing authorities. The Company’s policy is to include interest and penalties related to unrecognized tax benefits in income tax expense. The Company had no accrual for interest or penalties as of March 31, 2022. The Company files income tax returns with the Internal Revenue Service (“IRS”) and the state of California. Use of Estimates Generally accepted accounting principles require that the consolidated financial statements include estimates by management in the valuation of certain assets and liabilities. Significant matters requiring the use of estimates and assumptions include, but are not necessarily limited to, fair value of the Company’s stock, stock-based compensation, BCF (Beneficial Conversion Feature) liabilities feature of convertible debt, and valuation allowance relating to the Company’s deferred tax assets. Management uses its historical records and knowledge of its business in making these estimates. Management believes that its estimates and assumptions are reasonable, based on information that is available at the time they are made. Accordingly, actual results could differ from those estimates. Revenue Recognition The Company will recognize revenue from the sale of products and services in accordance with ASC 606, ”Revenue from Contracts with Customers, ” Stock Based Compensation The Company accounts for share-based compensation in accordance with the fair value recognition provision of FASB ASC 718, Compensation – Stock Compensation (“ASC 718”), prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on the estimated grant date fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period). The Company accounts for share-based compensation issued to non-employees and consultants in accordance with the provisions of FASB ASC 505, Equity–based Payments to Non-Employees (“ASC 505”). Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction is determined at the earlier of performance commitment date or performance completion date. Net Loss per Share Basic net loss per share is calculated by dividing the net loss for the period by the weighted-average number of common shares outstanding during the period. Diluted net loss per share is calculated by dividing the net loss for the period by the weighted-average number of common shares outstanding during the period, increased by potentially dilutive common shares ("dilutive securities") that were outstanding during the period. Dilutive securities include stock options and warrants granted, convertible debt, and convertible preferred stock. There were no potentially dilutive securities for the period ended March 31, 2022 and year ended June 30, 2021. Fair Value of Financial Instruments The Company follows FASB ASC 820, Fair Value Measurements and Disclosures Level 1: Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. Level 2: Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3: Pricing inputs that are generally unobservable inputs and not corroborated by market data. Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument. The carrying amounts reported in the Company’s consolidated financial statements for cash, accounts payable and accrued expenses approximate their fair value because of the immediate or short-term nature of these consolidated financial instruments. Derivative Liability FASB ASC 815, Derivatives and Hedging requires all derivatives to be recorded on the consolidated balance sheet at fair value. As of March 31, 2022, we used the Black-Scholes-Merton (BSM) model to estimate the fair value of the conversion feature of the convertible note. Key assumptions of the BSM model include the market price of our stock, the conversion price of the debt, applicable volatility rates, risk-free interest rates and the instrument’s remaining term. These assumptions require significant management judgment. In addition, changes in any of these variables during a period can result in material changes in the fair value (and resultant gains or losses) of this derivative instrument. Inventories Inventory, consisting of raw materials, work in process and products available for sale, are primarily accounted for using the first-in, first-out method (“FIFO”), and are valued at the lower of cost or net realizable value. This valuation requires management to make judgements based on currently available information, about the likely method of disposition, such as through sales to individual customers and returns to product vendors. As of March 31, 2022, the Company had inventories of approximately $66,390. The Company has no allowance for inventory reserves. Recent Accounting Pronouncements In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”) and also issued subsequent amendments to the initial guidance: ASU 2018-19, ASU 2019-04, and ASU 2019-05 (collectively, “Topic 326”). Topic 326 requires measurement and recognition of expected credit losses for financial assets held. The Company will be required to adopt this ASU for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The adoption of Topic 326 is not expected to have a material on the Company’s financial statements and financial statement disclosures.

Note 2 - Notes Payable

Note 2 - Notes Payable	9 Months Ended
	Mar. 31, 2022
Notes
Note 2 - Notes Payable	Note 2 – Notes Payable In March 2018, the Company issued notes that carry an 8% annual interest rate and mature through December 31, 2019. In December 2019, $5,119 of principal was converted into Company common stock and payments were made of $11,381. In March 2020, the note was exchanged for a convertible promissory note that accrues interest at 10% per annum and matured on March 11, 2021. The principal balance of the new note is $77,235 as of June 30, 2021. On August 21, 2021, The Company settled this note after the holder agreed to accept $40,000 payment to satisfy the total amount due. Hence, no additional interest was charged on the note. On July 3, 2019, the Company issued a $250,000 convertible promissory note (the “July 2019 Note”) to a lender (the “Lender”). According to the terms the Lender funded the July 2019 Note as follows: $100,000 upon the execution of the Note, $50,000 on August 1, 2019, $50,000 on September 1, 2019, and the remaining $50,000 on October 1, 2019. The outstanding principal balance of the Note shall bear interest at the rate of twelve percent (12%) per annum. The balance of the July 2019 Note was $250,000 on June 30, 2021 and matured on July 03, 2021. On August 28, 2021, the investor agreed to extend the note till July 03, 2022. On November 22, 2019, Company issued a $170,000 convertible promissory note (the “November 2019 Note”) to the Lender that accrues interest at 12% per annum. On November 22, 2021, the investor agreed to extend the note till November 21, 2022. The July and November Notes contain embedded derivatives, see Note 7. On July 14, 2020 and October 21, 2020, the Company sold convertible notes bearing 12% interest in the principal amounts of $340,000 and $348,000, respectively. Subject to certain ownership limitations, the notes will be convertible at the option of the holder at any time into shares of the Company’s common stock at an effective conversion price of $0.144. The embedded conversion features of these notes were valued at $85,000 and $135,333, respectively, and is amortized over the life of the notes. On January 12, 2021, the Company sold convertible notes bearing 12% interest on the principal amount of $360,000, respectively. The principal amount was agreed to be paid in two tranches of $180,000 each, received on February 19, 2021 and March 08, 2021. The note is subject to certain ownership limitations and will be convertible at the option of the holder at any time into shares of the Company’s common stock at an effective conversion rate of $0.144. The embedded conversion features of this note were valued at $35,500 and $7,500 for each tranche received and are amortized over the life of the note. On February 04, 2022, the Company sold convertible note bearing 12% interest in the principal amount of $350,000, respectively. The note will be paid in three tranches with first tranche of $100,000 received on March 28, 2022. The note is subject to certain ownership limitations and will be convertible at the option of the holder at any time into shares of the Company’s common stock at an effective conversion rate of $ 0.013. The embedded conversion features of this note was valued at $36,228 for the first tranche received and will be amortized over the life of the note. Amount Balance of notes payable, net of discount on June 30, 2021 $ 1,382,160 Amortization of Debt Discount 122,913 Interest Expense 68,729 New Issuances 100,000 Embedded Conversion Feature - New Issuance (168,729) Payment on Notes Payable (40,000) Gain on Settlement of Note Payable less Accrued Interest (37,235) Balance of notes payable, net of discount as of March 31, 2022 $ 1,427,838

Note 3 - Related Party Transact

Note 3 - Related Party Transactions	9 Months Ended
	Mar. 31, 2022
Notes
Note 3 - Related Party Transactions	Note 3 – Related Party Transactions Due to Officer During the year ending June 30, 2018, the Company received advances from its officer to pay for certain operating expenses. On December 29, 2021, the officer was paid back $5,000, leaving remaining balance due to the officer on March 31, 2022 of $1,428. The balance due to officer on June 30, 2021, was $6,428. There are no definitive repayment terms, and no interest is accruing on these advances.

Note 4 - Concentrations

Note 4 - Concentrations	9 Months Ended
	Mar. 31, 2022
Notes
Note 4 - Concentrations	Note 4 – Concentrations Cash Concentration The Company maintains its cash and cash equivalents at a financial institution which may, at times, exceed federally insured limits. As of March 31, 2022, the Company’s cash balance did not exceed the FDIC insurance limit. The Company has not experienced any losses in such accounts. Accounts outside the United States i.e Applife Shanghai, are not FDIC insured.

Note 5 - Commitments and Contin

Note 5 - Commitments and Contingencies	9 Months Ended
	Mar. 31, 2022
Notes
Note 5 - Commitments and Contingencies	Note 5 – Commitments and Contingencies Common Stock Payable As of March 31, 2022, and June 30, 2021, the Company owes $125,616 and $0 worth of common stock to vendors for services rendered, respectively. Other Risks On March 12, 2020, the World Health Organization declared COVID-19 to be a pandemic, and the COVID-19 pandemic has resulted in significant financial market volatility and uncertainty. A continuation or worsening of the levels of market disruption and volatility seen in the recent past could have an adverse effect on our ability to access capital, on our business, results of operations and financial condition, and on the market price of our common shares. While we did not incur significant disruptions from the COVID-19 pandemic during the nine months ended March 31, 2022, this situation could have an impact on our future business and results of operations in 2022 that may be material but cannot be reasonably estimated at this time due to numerous uncertainties.

Note 6 - Stockholders' Equity (

Note 6 - Stockholders' Equity (Deficit)	9 Months Ended
	Mar. 31, 2022
Notes
Note 6 - Stockholders' Equity (Deficit)	Note 6 – Stockholders’ Deficit As of March 31, 2022, and June 30, 2021, there were 148,543,635 and 135,524,617 shares of common stock issued and outstanding, respectively. On July 6, 2021, the Company entered into multiple subscription agreements with investors and issued 5,200,000 shares of common stock, priced at $0.10 per share, for an aggregate purchase price of $520,000. Common stock issued for services and stock options During the nine months ended March 31, 2022, the Company issued 3,819,018 shares of common stock to third parties for services valued at $144,141 with price at $0.08 and 0.0495 per share, respectively. During the nine months ended March 31, 2022 and 2021, the Company recognized stock compensation expense on outstanding restricted stock awards and option awards of $1,431,758, and $1,161,208, respectively. During nine months ended March 31, 2022, the Company granted 1,000,000 stock options, in the aggregate, to marketing consulting company. The options vest pro-rata over contract’s term, have exercise price of $0.10 and expire in five years from the date of grant. Options Weighted Average Exercise Price per Share Weighted Average Remaining Life (Years) Outstanding – June 30, 2021 4,094,959 $ 0.15 5 Granted 1,000,000 0.10 4.62 Forfeited - - - Exercised - - - Outstanding – March 31, 2022 5,094,959 $ 0.14 4.42 The Company recognized $169,700 of expense in connection with the options and valued with Black Scholes using the following inputs: Nine Months Ended March 31, 2022 Stock price $ 0.03 - 0.04 Exercise price $ 0.01 - 0.33 Expected term (in years) 3 - 5 Years Volatility (annual) 169 % Risk-free rate 0.09 – 2.28 %

Note 7 - Derivative Liability

Note 7 - Derivative Liability	9 Months Ended
	Mar. 31, 2022
Notes
Note 7 - Derivative Liability	Note 7 – Derivative Liability The Company issued debts that consist of the issuance of convertible notes with variable conversion provisions. The conversion terms of the convertible notes are variable based on certain factors, such as the future price of the Company’s common stock. The number of shares of common stock issuable upon conversion of the promissory note is indeterminate. Pursuant to ASC 815-15 Embedded Derivatives, the fair values of the variable conversion option and shares to be issued were recorded as derivative liabilities on the issuance date and revalued at each reporting period. A summary of quantitative information with respect to valuation methodology and significant unobservable inputs used for the Company’s common stock purchase warrants that are categorized within Level 3 of the fair value hierarchy for the nine months ended March 31, 2022 is as follows: Nine Months Ended March 31, 2022 Stock price $ 0.03 – 0.04 Exercise price $ 0.01 – 0.33 Contractual term (in years) 3 – 5 Years Volatility (annual) 169 % Risk-free rate 0.09 - 2.28 % The foregoing assumptions are reviewed quarterly and are subject to change based primarily on management’s assessment of the probability of the events described occurring. Accordingly, changes to these assessments could materially affect the valuations. Financial Liabilities Measured at Fair Value on a Recurring Basis Financial liabilities measured at fair value on a recurring basis are summarized below and disclosed on the balance sheet under Derivative liability – warrants and derivative liabilities: Fair value measured at March 31, 2022 Quoted prices in Significant other Significant active markets observable inputs unobservable inputs Fair value at (Level 1) (Level 2) (Level 3) March 31, 2022 Derivative liability $ - $ - $ 172,166 $ 172,166 Total $ - $ - $ 172,166 $ 172,166 Fair Value measured at June 30, 2021 Quoted prices in Significant other Significant active markets observable inputs unobservable inputs Fair value at (Level 1) (Level 2) (Level 3) June 30, 2021 Derivative liability $ - $ - $ 28,576 $ 28,576 Total $ - $ - $ 28,576 $ 28,576 The fair value accounting standards define fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is determined based upon assumptions that market participants would use in pricing an asset or liability. Fair value measurements are rated on a three-tier hierarchy as follows: ● Level 1 inputs: Quoted prices (unadjusted) for identical assets or liabilities in active markets; ● Level 2 inputs: Inputs, other than quoted prices included in Level 1, that are observable either directly or indirectly; and ● Level 3 inputs: Unobservable inputs for which there is little or no market data, which require the reporting entity to develop its own assumptions. There were no transfers between Level 1, 2 or 3 during the period ended March 31, 2022. During the nine months ended March 31, 2022 and 2021, the Company recorded loss of $25,139 and $78,245, respectively, from the change in fair value of derivative liability. The following table presents changes in Level 3 liabilities measured at fair value for the period ended March 31, 2022: Derivative Liability Balance – June 30, 2021 $ 28,576 Changes due to issuances 168,729 Change in fair value of derivative liability (25,139) Balance – March 31, 2022 $ 172,166 The balance of the derivative liability at March 31, 2022 and June 30, 2021 was $172,166 and $28,576, respectively.

Note 8 - Subsequent Events

Note 8 - Subsequent Events	9 Months Ended
	Mar. 31, 2022
Notes
Note 8 - Subsequent Events	Note 8 – Subsequent Events The Company has evaluated subsequent events through the filing of this Quarterly Report on Form 10-Q and determined that no material events occurred.

Note 1 - Organization and Sum_2

Note 1 - Organization and Summary of Significant Accounting Policies: Organization (Policies)	9 Months Ended
	Mar. 31, 2022
Policies
Organization	Organization APPlife Digital Solutions Inc. (the “Company”) is a business incubator and portfolio manager that uses digital technology to create and invest in e-commerce and cloud-based solutions. The Company was formed March 5, 2018 in Nevada and has offices in San Francisco, California and Shanghai, China. The Company’s mission is using digital technology to create APPs and websites that make life, business and living easier, more efficient and just smarter. Rooster Essentials APP SPV, LLC (the “Rooster”), incorporated on April 9, 2019, is a wholly owned subsidiary of the Company. Rooster is a fully customizable men’s ecommerce platform that delivers daily use grooming needs and essential items. B2BCHX SPV LLC (the “B2BCHX”), incorporated on June 5, 2019, is a wholly owned subsidiary of the Company. B2BCHX does an independent background check on mainland Chinese companies for small businesses globally. Office Hop, incorporated on January 28, 2021, is a wholly owned subsidiary of the Company. Office Hop is a global sharing model platform for short term rentals of office and meeting rooms. Users can find an office or conference space for hourly, half-day, full-day, or weekly rental. Hosts can list their spare office or meeting rooms.

Note 1 - Organization and Sum_3

Note 1 - Organization and Summary of Significant Accounting Policies: Going Concern (Policies)	9 Months Ended
	Mar. 31, 2022
Policies
Going Concern	Going Concern The Company has generated losses and negative cash flows from operations since inception. The Company has historically financed its operations from equity financing. The Company anticipates additional equity financings to fund operations in the future. Should management fail to adequately address the issue, the Company may have to reduce its business activities or curtail its operations. There can be no assurance that any additional financings, would be available to the Company on satisfactory terms and conditions if at all. The current pandemic known as COVID-19 as described in Note 5, creates additional uncertainty. The accompanying consolidated financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and classification of liabilities and commitments in the normal course of business. The accompanying consolidated financial statements do not reflect any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classifications of liabilities that might result if the Company is unable to continue as a going concern.

Note 1 - Organization and Sum_4

Note 1 - Organization and Summary of Significant Accounting Policies: Basis of Presentation (Policies)	9 Months Ended
	Mar. 31, 2022
Policies
Basis of Presentation	Basis of Presentation The Company’s unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for the interim financial information and with instructions to Form 10-Q and Article 10 of Regulation S-X. The unaudited condensed consolidated financial statements include the accounts of all subsidiaries in which the Company holds a controlling financial interest as of the financial statement date. All intercompany transactions have been eliminated in consolidation. However, in the opinion of the management of the Company, all adjustments necessary for a fair presentation of the financial position and operating results have been included in these statements. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10–K for the fiscal year ended June 30, 2021, as filed with the SEC on September 24, 2021. Operating results for the nine months ended March 31, 2022 are not necessarily indicative of the results that may be expected for any subsequent quarters or for the fiscal year ending June 30, 2022.

Note 1 - Organization and Sum_5

Note 1 - Organization and Summary of Significant Accounting Policies: Cash and Cash Equivalents (Policies)	9 Months Ended
	Mar. 31, 2022
Policies
Cash and Cash Equivalents	Cash and Cash Equivalents For the purpose of the statement of cash flows, the Company considers cash equivalents to include cash and investments with an original maturity of three months or less.

Note 1 - Organization and Sum_6

Note 1 - Organization and Summary of Significant Accounting Policies: Income Taxes (Policies)	9 Months Ended
	Mar. 31, 2022
Policies
Income Taxes	Income Taxes The Company has adopted guidance issued by the FASB that clarifies the accounting for uncertainty in income taxes recognized in an enterprise's financial statements and prescribes a recognition threshold of more likely than not and a measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. In making this assessment, a company must determine whether it is more likely than not that a tax position will be sustained upon examination, based solely on the technical merits of the position and must assume that the tax position will be examined by taxing authorities. The Company’s policy is to include interest and penalties related to unrecognized tax benefits in income tax expense. The Company had no accrual for interest or penalties as of March 31, 2022. The Company files income tax returns with the Internal Revenue Service (“IRS”) and the state of California.

Note 1 - Organization and Sum_7

Note 1 - Organization and Summary of Significant Accounting Policies: Use of Estimates (Policies)	9 Months Ended
	Mar. 31, 2022
Policies
Use of Estimates	Use of Estimates Generally accepted accounting principles require that the consolidated financial statements include estimates by management in the valuation of certain assets and liabilities. Significant matters requiring the use of estimates and assumptions include, but are not necessarily limited to, fair value of the Company’s stock, stock-based compensation, BCF (Beneficial Conversion Feature) liabilities feature of convertible debt, and valuation allowance relating to the Company’s deferred tax assets. Management uses its historical records and knowledge of its business in making these estimates. Management believes that its estimates and assumptions are reasonable, based on information that is available at the time they are made. Accordingly, actual results could differ from those estimates.

Note 1 - Organization and Sum_8

Note 1 - Organization and Summary of Significant Accounting Policies: Revenue Recognition (Policies)	9 Months Ended
	Mar. 31, 2022
Policies
Revenue Recognition	Revenue Recognition The Company will recognize revenue from the sale of products and services in accordance with ASC 606, ”Revenue from Contracts with Customers, ”

Note 1 - Organization and Sum_9

Note 1 - Organization and Summary of Significant Accounting Policies: Stock Based Compensation (Policies)	9 Months Ended
	Mar. 31, 2022
Policies
Stock Based Compensation	Stock Based Compensation The Company accounts for share-based compensation in accordance with the fair value recognition provision of FASB ASC 718, Compensation – Stock Compensation (“ASC 718”), prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on the estimated grant date fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period). The Company accounts for share-based compensation issued to non-employees and consultants in accordance with the provisions of FASB ASC 505, Equity–based Payments to Non-Employees (“ASC 505”). Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction is determined at the earlier of performance commitment date or performance completion date.

Note 1 - Organization and Su_10

Note 1 - Organization and Summary of Significant Accounting Policies: Net Loss per Share (Policies)	9 Months Ended
	Mar. 31, 2022
Policies
Net Loss per Share	Net Loss per Share Basic net loss per share is calculated by dividing the net loss for the period by the weighted-average number of common shares outstanding during the period. Diluted net loss per share is calculated by dividing the net loss for the period by the weighted-average number of common shares outstanding during the period, increased by potentially dilutive common shares ("dilutive securities") that were outstanding during the period. Dilutive securities include stock options and warrants granted, convertible debt, and convertible preferred stock. There were no potentially dilutive securities for the period ended March 31, 2022 and year ended June 30, 2021.

Note 1 - Organization and Su_11

Note 1 - Organization and Summary of Significant Accounting Policies: Fair Value of Financial Instruments (Policies)	9 Months Ended
	Mar. 31, 2022
Policies
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company follows FASB ASC 820, Fair Value Measurements and Disclosures Level 1: Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. Level 2: Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3: Pricing inputs that are generally unobservable inputs and not corroborated by market data. Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument. The carrying amounts reported in the Company’s consolidated financial statements for cash, accounts payable and accrued expenses approximate their fair value because of the immediate or short-term nature of these consolidated financial instruments.

Note 1 - Organization and Su_12

Note 1 - Organization and Summary of Significant Accounting Policies: Derivative Liability (Policies)	9 Months Ended
	Mar. 31, 2022
Policies
Derivative Liability	Derivative Liability FASB ASC 815, Derivatives and Hedging requires all derivatives to be recorded on the consolidated balance sheet at fair value. As of March 31, 2022, we used the Black-Scholes-Merton (BSM) model to estimate the fair value of the conversion feature of the convertible note. Key assumptions of the BSM model include the market price of our stock, the conversion price of the debt, applicable volatility rates, risk-free interest rates and the instrument’s remaining term. These assumptions require significant management judgment. In addition, changes in any of these variables during a period can result in material changes in the fair value (and resultant gains or losses) of this derivative instrument.

Note 1 - Organization and Su_13

Note 1 - Organization and Summary of Significant Accounting Policies: Inventories (Policies)	9 Months Ended
	Mar. 31, 2022
Policies
Inventories	Inventories Inventory, consisting of raw materials, work in process and products available for sale, are primarily accounted for using the first-in, first-out method (“FIFO”), and are valued at the lower of cost or net realizable value. This valuation requires management to make judgements based on currently available information, about the likely method of disposition, such as through sales to individual customers and returns to product vendors. As of March 31, 2022, the Company had inventories of approximately $66,390. The Company has no allowance for inventory reserves.

Note 1 - Organization and Su_14

Note 1 - Organization and Summary of Significant Accounting Policies: Recent Accounting Pronouncements (Policies)	9 Months Ended
	Mar. 31, 2022
Policies
Recent Accounting Pronouncements	Recent Accounting Pronouncements In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”) and also issued subsequent amendments to the initial guidance: ASU 2018-19, ASU 2019-04, and ASU 2019-05 (collectively, “Topic 326”). Topic 326 requires measurement and recognition of expected credit losses for financial assets held. The Company will be required to adopt this ASU for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The adoption of Topic 326 is not expected to have a material on the Company’s financial statements and financial statement disclosures.

Note 2 - Notes Payable_ Schedul

Note 2 - Notes Payable: Schedule of Debt (Tables)	9 Months Ended
	Mar. 31, 2022
Tables/Schedules
Schedule of Debt	Amount Balance of notes payable, net of discount on June 30, 2021 $ 1,382,160 Amortization of Debt Discount 122,913 Interest Expense 68,729 New Issuances 100,000 Embedded Conversion Feature - New Issuance (168,729) Payment on Notes Payable (40,000) Gain on Settlement of Note Payable less Accrued Interest (37,235) Balance of notes payable, net of discount as of March 31, 2022 $ 1,427,838

Note 6 - Stockholders' Equity_2

Note 6 - Stockholders' Equity (Deficit): Schedule of Stock Option Activity (Tables)	9 Months Ended
	Mar. 31, 2022
Tables/Schedules
Schedule of Stock Option Activity	Options Weighted Average Exercise Price per Share Weighted Average Remaining Life (Years) Outstanding – June 30, 2021 4,094,959 $ 0.15 5 Granted 1,000,000 0.10 4.62 Forfeited - - - Exercised - - - Outstanding – March 31, 2022 5,094,959 $ 0.14 4.42

Note 6 - Stockholders' Equity_3

Note 6 - Stockholders' Equity (Deficit): Schedule of Assumptions Used (Tables)	9 Months Ended
	Mar. 31, 2022
Tables/Schedules
Schedule of Assumptions Used	Nine Months Ended March 31, 2022 Stock price $ 0.03 - 0.04 Exercise price $ 0.01 - 0.33 Expected term (in years) 3 - 5 Years Volatility (annual) 169 % Risk-free rate 0.09 – 2.28 %

Note 7 - Derivative Liability_

Note 7 - Derivative Liability: Schedule of valuation methodology (Tables)	9 Months Ended
	Mar. 31, 2022
Tables/Schedules
Schedule of valuation methodology	Nine Months Ended March 31, 2022 Stock price $ 0.03 – 0.04 Exercise price $ 0.01 – 0.33 Contractual term (in years) 3 – 5 Years Volatility (annual) 169 % Risk-free rate 0.09 - 2.28 %

Note 7 - Derivative Liability_2

Note 7 - Derivative Liability: Fair Value, Liabilities Measured on Recurring Basis (Tables)	9 Months Ended
	Mar. 31, 2022
Tables/Schedules
Fair Value, Liabilities Measured on Recurring Basis	Fair value measured at March 31, 2022 Quoted prices in Significant other Significant active markets observable inputs unobservable inputs Fair value at (Level 1) (Level 2) (Level 3) March 31, 2022 Derivative liability $ - $ - $ 172,166 $ 172,166 Total $ - $ - $ 172,166 $ 172,166 Fair Value measured at June 30, 2021 Quoted prices in Significant other Significant active markets observable inputs unobservable inputs Fair value at (Level 1) (Level 2) (Level 3) June 30, 2021 Derivative liability $ - $ - $ 28,576 $ 28,576 Total $ - $ - $ 28,576 $ 28,576

Note 7 - Derivative Liability_3

Note 7 - Derivative Liability: Schedule of Derivative Liabilities at Fair Value (Tables)	9 Months Ended
	Mar. 31, 2022
Tables/Schedules
Schedule of Derivative Liabilities at Fair Value	The following table presents changes in Level 3 liabilities measured at fair value for the period ended March 31, 2022: Derivative Liability Balance – June 30, 2021 $ 28,576 Changes due to issuances 168,729 Change in fair value of derivative liability (25,139) Balance – March 31, 2022 $ 172,166

Note 2 - Notes Payable (Details

Note 2 - Notes Payable (Details) - USD ($)

Aug. 28, 2021

Aug. 21, 2021

Oct. 21, 2020

Jul. 14, 2020

Nov. 22, 2019

Jul. 03, 2019

Mar. 31, 2020

Dec. 31, 2019

Mar. 31, 2018

Mar. 31, 2021

Mar. 31, 2021

Mar. 31, 2022

Feb. 04, 2022

Jun. 30, 2021

Mar. 08, 2021

Jan. 19, 2021

Jan. 12, 2021

Payment of notes payable with issuance of common stock, Value

$ 0

$ 74,970

Notes payable - current, net

$ 1,327,838

$ 595,235

March 2018 Note

Debt Instrument, Interest Rate During Period

8.00%

Debt Instrument, Maturity Date

Dec. 31, 2019

Payment of notes payable with issuance of common stock, Value

$ 5,119

Payments on notes payable

$ 11,381

March 2020 Note

Debt Instrument, Maturity Date

Mar. 11, 2021

Debt Instrument, Maturity Date

10.00%

Notes payable - current, net

77,235

Settlement Payment on Debt

$ 40,000

July 2019 Note | Lender

Debt Instrument, Interest Rate During Period

12.00%

Debt Instrument, Maturity Date

Jul. 3, 2022

Notes payable - current, net

$ 250,000

Principal amount

$ 250,000

November 2019 Note | Lender

Debt Instrument, Interest Rate During Period

12.00%

Principal amount

$ 170,000

April 2020 Note | Investor

Payment of notes payable with issuance of common stock, Value

$ 0.12

$ 0.12

Principal amount

$ 348,000

$ 340,000

Debt Instrument, Convertible, Conversion Price

$ 0.144

$ 0.144

Embedded Conversion Feature

$ 135,333

$ 85,000

January 2021 Note | Investor

Debt Instrument, Maturity Date

12.00%

Principal amount

$ 360,000

January 2021 Note | Tranches 1

Principal amount

$ 180,000

Embedded Conversion Feature

$ 35,500

January 2021 Note | Tranches 2

Principal amount

180,000

Embedded Conversion Feature

$ 7,500

February 2022 Note | Investor

Debt Instrument, Maturity Date

12.00%

Principal amount

$ 350,000

February 2022 Note | Tranches 1

Principal amount

100,000

Embedded Conversion Feature

$ 36,228

Note 2 - Notes Payable_ Sched_2

Note 2 - Notes Payable: Schedule of Debt (Details) - USD ($)	9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Jun. 30, 2021
Details
Notes Payable	$ 1,427,838		$ 1,382,160
Amortization of debt discount	122,913
Interest Expense	68,729
Proceeds from notes payable	100,000	$ 1,048,000
Increase in derivative liability upon issuance of convertible note	(168,729)	$ 0
Payments on notes payable	(40,000)
Payment of notes payable with issuance of common stock	$ (37,235)

Note 3 - Related Party Transa_2

Note 3 - Related Party Transactions (Details) - USD ($)	Mar. 31, 2022	Jun. 30, 2021
Details
Due to officer	$ 1,428	$ 6,428

Note 5 - Commitments and Cont_2

Note 5 - Commitments and Contingencies (Details) - USD ($)	Mar. 31, 2022	Jun. 30, 2021
Details
Common stock payable	$ 125,616	$ 0

Note 6 - Stockholders' Equity_4

Note 6 - Stockholders' Equity (Deficit) (Details) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021	Jun. 30, 2021
Common Stock, Shares, Outstanding	148,543,635		148,543,635		135,524,617
Common stock issued for cash, Value		$ 0	$ 520,000	$ 120,000
Common stock issued for services, Value	$ 39,858	$ 71,010	144,141	465,378
Share-based Payment Arrangement, Expense			$ 1,431,758	$ 1,161,208
Options granted			1,000,000
Common Stock
Common stock issued for cash, Shares		0	5,200,000	1,200,000
Common stock issued for cash, Value		$ 0	$ 5,200	$ 1,200
Common stock issued for services, Shares	1,898,023	527,714	3,819,018	5,229,030
Common stock issued for services, Value	$ 1,898	$ 528	$ 3,819	$ 5,230

Note 6 - Stockholders' Equity_5

Note 6 - Stockholders' Equity (Deficit): Schedule of Stock Option Activity (Details) - $ / shares	9 Months Ended
	Mar. 31, 2022	Jun. 30, 2021
Details
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	5,094,959	4,094,959
Weighted Average Exericse Price, Balance	$ 0.14	$ 0.15
Options granted	1,000,000
Weighted Average Exericse Price, Granted	$ 0.10
Weighted Average Remaining Life, granted	4 years 7 months 13 days
Options forfeited	0
Weighted Average Exericse Price, Forfeited	$ 0
Options exercised	0
Weighted Average Exericse Price, Exercised	$ 0
Weighted Average Remaining Life, outstanding	4 years 5 months 1 day

Note 6 - Stockholders' Equity_6

Note 6 - Stockholders' Equity (Deficit): Schedule of Assumptions Used (Details)	9 Months Ended
	Mar. 31, 2022$ / shares
Volatility (annual)	169.00%
Minimum
Stock Price	$ 0.03
Exercise Price	$ 0.01
Expect term (in years)	3 years
Risk-free rate	0.09%
Maximum
Stock Price	$ 0.04
Exercise Price	$ 0.33
Expect term (in years)	5 years
Risk-free rate	2.28%
Stock Options
Volatility (annual)	169.00%
Stock Options | Minimum
Stock Price	$ 0.03
Exercise Price	$ 0.01
Expect term (in years)	3 years
Risk-free rate	0.09%
Stock Options | Maximum
Stock Price	$ 0.04
Exercise Price	$ 0.33
Expect term (in years)	5 years
Risk-free rate	2.28%

Note 7 - Derivative Liability_4

Note 7 - Derivative Liability: Schedule of valuation methodology (Details)	9 Months Ended
	Mar. 31, 2022$ / shares
Volatility (annual)	169.00%
Minimum
Stock Price	$ 0.03
Exercise Price	$ 0.01
Expect term (in years)	3 years
Risk-free rate	0.09%
Maximum
Stock Price	$ 0.04
Exercise Price	$ 0.33
Expect term (in years)	5 years
Risk-free rate	2.28%

Note 7 - Derivative Liability_5

Note 7 - Derivative Liability: Fair Value, Liabilities Measured on Recurring Basis (Details) - USD ($)	Mar. 31, 2022	Jun. 30, 2021
Fair Value, Inputs, Level 1
Derivative liabilities	$ 0	$ 0
Fair Value, Inputs, Level 2
Derivative liabilities	0	0
Fair Value, Inputs, Level 3
Derivative liabilities	172,166	28,576
Derivative liabilities	$ 172,166	$ 28,576

Note 7 - Derivative Liability_6

Note 7 - Derivative Liability: Schedule of Derivative Liabilities at Fair Value (Details) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021	Jun. 30, 2021
Details
Derivative liabilities	$ 172,166		$ 172,166		$ 28,576
Increase in derivative liability upon issuance of convertible note			168,729	$ 0
Change in fair value of derivative liability	$ (616)	$ (75,733)	$ (25,139)	$ (78,245)

Note 7 - Derivative Liability (

Note 7 - Derivative Liability (Details) - USD ($)	Mar. 31, 2022	Jun. 30, 2021
Details
Derivative liabilities	$ 172,166	$ 28,576